AI Generated Image
New Treatments Show Promise for Two of the Most Deadly Types of Cancer
Newsweek • • health
Key Points:
- Researchers at Washington University School of Medicine have improved a minimally invasive laser treatment for glioblastoma, showing that destroying 91% or more of the tumor can extend patient survival to 2.1 years, surpassing typical surgery outcomes.
- The laser procedure avoids extensive brain surgery, requiring only a tiny incision and short hospital stay, potentially offering better quality of life and faster recovery for glioblastoma patients.
- At Kindai University in Japan, scientists identified that a subset (5%) of clear cell ovarian cancers with high IL-17 protein activity respond well to immunotherapy, which could serve as a new biomarker for treatment selection.
- IL-17 triggers immune activation within tumors, enhancing the effectiveness of immunotherapy in ovarian cancer models and potentially helping to identify patients who will benefit most from such treatments.
- Experts caution that these findings do not represent cures but provide promising advances in tailoring treatments to improve survival and quality of life for patients with these challenging cancers.
